Angela Zhou

Manager of Scientific Analysis and Insights, CAS

Bio

Angela Zhou serves as the Executive Editor of CAS Insights and the Lead Scientist in Life Sciences at CAS. Dr. Zhou earned her Ph.D. in Molecular Pharmacology and Toxicology from the University of Southern California, followed by postdoctoral training in cell biology at Johns Hopkins School of Medicine and specialized research in cancer therapeutics at Harvard Medical School.

Prior to joining CAS, Dr. Zhou held faculty positions at Missouri State University and Denison University, concentrating on teaching and research of cancer biology, cell signaling and biochemistry. At CAS, she leads a multidisciplinary team of research and data scientists who leverage comprehensive scientific databases. Dr. Zhou's unique blend of scientific expertise and data analytics leadership enables her team to deliver strategic intelligence, helping organizations navigate emerging trends and opportunities across chemistry, life sciences, and materials science.

Biotechnology

Extremophiles: Unlocking biomedical and industrial innovations from life at the edge

Extremophiles are microorganisms that survive in Earth’s harshest environments. Find out how their unique capabilities are changing biomedicine, environmental clean-ups, and more.
|见解报告
Biotechnology

Molecular de-extinction opens possibilities for new antibiotics

Molecular de-extinction revives genes and proteins from ancient sources, and it may hold the key to new antibiotics that fight drug-resistant pathogens.
|文章
新兴科学

The future of lipid-based drug delivery

Watch the recording of our webinar where experts from CAS, AstraZeneca, and The Ohio State University explored the current landscape and future directions of lipid-based drug delivery.
|网络研讨会
新兴科学

是友非敌:肠道微生物组利于改善健康

肠道微生物组是一个由数万亿细菌组成的复杂生态系统,这些细菌存活在我们的消化道中,具有提供免疫力、改善心理健康和提供治疗选择等健康益处。 近年来,人们对微生物组疗法治疗各种疾病的潜力越来越感兴趣。 随着我们对肠道微生物组的理解不断加深,我们有望在未来几年看到微生物组疗法的更多进展。
|文章
药物开发

ACE2:靶向疾病发病机制中的潜在重要受体

了解更多 ACE2 相关信息,该重要蛋白仍是 COVID-19 和许多其他病毒感染的关键靶点。 本文概述了有关靶向 ACE2 蛋白的出版物、里程碑意义事件和未来应用的新兴趋势和洞察。
|文章
新兴科学

抑郁症和创伤后应激障碍(PTSD)的新希望

最近的临床试验结果表明,娱乐性迷幻药,如LSD、MDMA,以及裸盖菇素,在适当控制剂量和给药时有积极的治疗效果。 阅览最新研究。
|文章